Moreover, in the hippocampus of the ischemic groups, as well as in the AP39 pretreated groups, the downregulation of caspase 3 activation may arise from the enhanced signaling of NGF-TrkA, and this is consistent with other data indicating the protective effects of NGF during a stroke [70,71]. This evidence concerns the gene NTRK1 and stroke disorder.